PDS Biotechnology Files Q1 2025 10-Q
Ticker: PDSB · Form: 10-Q · Filed: May 14, 2025 · CIK: 1472091
| Field | Detail |
|---|---|
| Company | Pds Biotechnology Corp (PDSB) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financials
TL;DR
PDS Biotech Q1 2025 10-Q filed. Financials updated.
AI Summary
PDS Biotechnology Corp. filed its 10-Q for the period ending March 31, 2025. The company, formerly Edge Therapeutics, Inc., is based in Princeton, NJ. The filing covers the first quarter of 2025 and provides financial data for the periods ending March 31, 2025, December 31, 2024, and March 31, 2024.
Why It Matters
This filing provides investors with an update on PDS Biotechnology's financial health and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a biotechnology company, PDS Biotechnology faces inherent risks related to drug development, clinical trials, and regulatory approvals.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Covers the first quarter of 2025)
- 2025-05-14 — Filing Date (Date the 10-Q was submitted)
Key Players & Entities
- PDS Biotechnology Corp. (company) — Filer of the 10-Q
- Edge Therapeutics, Inc. (company) — Former name of PDS Biotechnology Corp.
- Princeton, NJ (location) — Location of PDS Biotechnology Corp.
- March 31, 2025 (date) — End of the reporting period
- 20250514 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
What was PDS Biotechnology Corp.'s former company name?
PDS Biotechnology Corp.'s former company name was Edge Therapeutics, Inc.
Where is PDS Biotechnology Corp. located?
PDS Biotechnology Corp. is located in Princeton, NJ.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 14, 2025.
What fiscal year end does PDS Biotechnology Corp. observe?
PDS Biotechnology Corp. observes a fiscal year end of December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding PDS Biotechnology Corp (PDSB).